The use of generative artificial intelligence (AI) in clinical trial recruitment is rapidly changing how participants are identified, engaged, and enrolled. While the technology promises efficiency and broader reach, it also raises urgent ethical concerns. First, algorithmic bias in recruitment systems may reproduce or deepen health disparities, threatening efforts to build representative and inclusive clinical studies. Second, reliance on AI-generated patient materials complicates informed consent and transparency, since tailored outputs can obscure critical risks, oversimplify complex medical information, or frame participation in ways that undermine trust. Third, the integration of AI into recruitment workflows necessitates enhanced frameworks for accountability and responsible governance. Unlike traditional recruitment processes, generative AI involves layers of opacity, raising difficult questions about responsibility for errors, bias, and participant harm. Without strong regulatory oversight, the rapid adoption of AI-driven tools risks undermining participant protections and public trust in clinical research.
 
Kalina Kamenova PhD is Founder and Research Director of Canadian Institute For Genomics And Society | Toronto. Her work integrates bioethics, science policy, and public engagement strategies to shape evidence-based decisions in health and biomedical innovation, including genomics, precision medicine, stem cell and regenerative therapies, and artificial intelligence (AI) in healthcare. As Founder and Research Director of the Canadian Institute for Genomics and Society (Genomics4S), I have advanced participatory research, ethical governance, and policy innovation in emerging biotechnologies. Partnering with leading researchers, scientists, policymakers, and industry stakeholders, I have enabled strategic collaboration on initiatives that navigate the ethical and societal dimensions of biomedical innovation. With prior leadership experience at Loyalist College’s Applied Research and Innovation Office and University of Alberta’s Centre for Public Involvement, I have also contributed to fostering cross-sectoral innovation through applied research, policy development, and strategic partnerships. My executive and management expertise spans research administration, grant development, research ethics, team-building, and stakeholder engagement. I am driven by a commitment to responsible research and innovation, ensuring inclusive public discourse around transformative scientific advancements.

Other Posts

Empire of AI by Karen Hao is an investigative account of the rise of OpenAI and the new frontier of artificial intelligence. With vivid reportage from Silicon Valley and the Global South, Hao exposes how [...]

Join the Conversation: Bioethics, AI Politics, and a New World Order Online Winter School | December 15-20, 2025 The world is at a crossroads, facing complex challenges that require a deep understanding of the intersection [...]

New research from Washington University School of Medicine shows Alzheimer’s disease disrupts the brain’s circadian clock, disturbing the day–night rhythm of hundreds of genes vital for brain health. This circadian disturbance results in inflammation and [...]

The article describes how the author’s mother, a kidney-transplant patient in China, increasingly turned to the AI medical chatbot DeepSeek for health advice, finding it more comforting, accessible, and “humane” than busy hospital doctors. However, [...]

ChatGPT has surpassed 120 million monthly users in Europe, possibly making it subject to the EU’s strictest Digital Services Act (DSA) rules.The DSA imposes tougher transparency and safety requirements on platforms with over 45 million [...]

Nobel Laureate Peter Agre, MD argues that science can transcend politics and unite people through evidence and empathy.In his new book, Can Scientists Succeed Where Politicians Fail?, Agre shares insights from a life in discovery [...]